Bidda Sovereign Intelligence · 10,090 Verified Nodes · 39 Sovereign Pillars

EU Pharmaceutical Regulation (2022/0134) - Article 5: Marketing Authorisation Requirements

EU Pharmaceutical Regulation (proposed, replacing Directive 2001/83/EC) Article 5 maintains the core requirement that no medicinal product may be placed…

What EU Pharmaceutical Regulation (2022/0134) - Article 5: Marketing Authorisation Requirements requires

EU Pharmaceutical Regulation (proposed, replacing Directive 2001/83/EC) Article 5 maintains the core requirement that no medicinal product may be placed on the EU market without a marketing authorisation (MA) granted by the European Medicines Agency (EMA) under the centralised procedure or by a national competent authority under national procedures. The MA application must include full pharmaceutical, non-clinical, and clinical data demonstrating quality, safety, and efficacy. The revised Regulation introduces environmental risk assessment as a mandatory MA application component and strengthens post-authorisation monitoring obligations. EMA and national competent authorities jointly enforce MA compliance.

Pillar: Pharmaceuticals & Life Sciences · Authority: European Medicines Agency (EMA) · Version: 2.0.0 · Last updated:

Primary source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52022PC0134

SHA-256 integrity: af30fa610001b691bc8f3932d006c34cb5b9c540a38efa98c0419edb69525b41

Primary Citations — 8 traced to source

  • {"source":"EU Pharmaceutical Regulation Proposal COM(2022) 134 - Article 5: Marketing Authorisation Requirement","url":"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52022PC0134","type":"primary_legislation"}
  • {"source":"EU Directive 2001/83/EC - Article 6: Prohibition on placing medicinal products on the market without MA (predecessor to 2022/0134)","url":"https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32001L0083","type":"primary_legislation"}

+ 6 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.

Access

⚠ Important: Human Verification Required

Bidda compliance nodes are reference intelligence, not legal advice. Every node must be reviewed by a qualified compliance professional or legal counsel before implementation in any enterprise workflow, regulated system, or compliance programme. See bidda.com/disclaimer for full terms.